Ataxia telangiectasia (AT) is a human hereditary syndrome whose underlying gene product, ataxia telangiectasia mutated (ATM) protein kinase, is involved in multiple intracellular signaling pathways. We demonstrated previously that AT fibroblasts are defective in intracellular Ca 2+ mobilization in response to both stressinducing and mitogenic stimuli. To extend these findings, normal and AT cells were exposed to serum in the presence of different concentrations of extracellular Ca ] o (0.0022 mm) conditions, normal cells were slow and inefficient in their responses, whereas AT cells showed a substantial improvement in all three end points. These findings demonstrate that loss of ATM kinase function deregulates the extracellular calciumsensing receptor (CaR). This malfunction presumably arises from a post-transcriptional event, since CaR mRNA proved to be normal in AT cells. Together, our data suggest that ATM may mediate cell response to mitogenic factors by tightly regulating the set point of the CaR and thereby modulating the crosstalk between this metabotropic receptor and growth factor receptors. Alternatively, the faulty sensing of extracellular calcium in AT cells may be secondary to a state of chronic oxidative stress attributable to ATM deficiency.
Ataxia telangiectasia (AT) is a human hereditary syndrome whose underlying gene product, ataxia telangiectasia mutated (ATM) protein kinase, is involved in multiple intracellular signaling pathways. We demonstrated previously that AT fibroblasts are defective in intracellular Ca 2+ mobilization in response to both stressinducing and mitogenic stimuli. To extend these findings, normal and AT cells were exposed to serum in the presence of different concentrations of extracellular Ca 2+ ([Ca 2+ ] o ), and release of intracellular Ca 2+ , activation of calmodulin-dependent protein kinase II and phosphorylation of kinases ERK1 and 2 were monitored. When maintained in high [Ca 2+ ] o (0.42 mm), normal fibroblasts responded to serum introduction more rapidly and efficiently than did AT cells. Unexpectedly, decreasing the [Ca 2+ ] o in the medium had a diametrically opposite effect. Under low [Ca 2+ ] o (0.0022 mm) conditions, normal cells were slow and inefficient in their responses, whereas AT cells showed a substantial improvement in all three end points. These findings demonstrate that loss of ATM kinase function deregulates the extracellular calciumsensing receptor (CaR). This malfunction presumably arises from a post-transcriptional event, since CaR mRNA proved to be normal in AT cells. Together, our data suggest that ATM may mediate cell response to mitogenic factors by tightly regulating the set point of the CaR and thereby modulating the crosstalk between this metabotropic receptor and growth factor receptors. Alternatively, the faulty sensing of extracellular calcium in AT cells may be secondary to a state of chronic oxidative stress attributable to ATM deficiency. Oncogene ( Shiloh, 1997; Hall and Angele, 1999) . Its cardinal hallmarks include: progressive neurovascular deterioration, impaired immunity, aberrant organogenesis, cancer (leukemia/lymphoma) predisposition, premature aging and catastrophic reaction to radiotherapy. The pleiotropic nature of the syndrome is further exemplified by a cellular phenotype that features hypersensitivity to ionizing radiation, chromosomal instability, faulty activation of cell cycle checkpoints and impaired growth properties. The responsible gene, denoted ataxia telangiectasia mutated (ATM), codes for a large protein kinase (ATM). This enzyme supervises a complex network of interlocking signaling cascades involved in response to cellular DNA injury, for example, doublestrand breaks, induced either by oxygen-free radicals or formed inadvertently during normal DNA transactions (e.g. homologous and Y(D)J recombination) (Rotman and Shiloh, 1999; Zhou and Elledge, 2000; Durocher and Jackson, 2001) . For example, upon sensing, most probably, a double-strand break in radiation-damaged cells, ATM activates two branches of the S-phase checkpoint cascade, that is, Chk2/CDC25A-mediated and NBS1/SMC1-mediated pathways (Falck et al., 2001; Yazdi et al., 2002) . AT cells are unable to effect these two S-phase checkpoint pathways and hence fail to undergo S-phase delay postirradiation. A growing body of evidence suggests that ATM may also be intimately involved in general signaling cascades, including those controlling cell proliferation, differentiation and death (Soares et al., 1998; Fukao et al., 1999; Heyer et al., 2000) . Notably, there is a complex interplay between ATM and different growth factors that oversees the transcriptional regulation of certain growth factor receptors and ATM itself Keating et al., 2001; Peretz et al., 2001) . Moreover, ATM participates in the insulin signaling pathway (Yang and Kastan, 2000) . In short, it is becoming increasingly clear that the ATM kinase is involved in a variety of cellular processes.
Ionized calcium is an indispensable and omnipotent intracellular messenger responsible for controlling numerous processes underlying cell cycle progression, (Brown, 2000) . In transducing the extracellular signal to the interior of the cell, the CaR employs second messengers (e.g. cAMP, intracellular Ca
2+
) and activates MAP kinases (MAPKs) (Chattopadhyay, 2000) . The sensing of the extracellular Ca 2+ concentration ([Ca 2+ ] o ) occurs in a wide array of cell types. Indeed, the CaR, apart from its pivotal role in systemic calcium homeostasis, is now being considered as a possible key regulator of cell proliferation, differentiation and chemotaxis (Brown, 2000; Chattopadhyay, 2000) . Moreover, its deregulation is causally linked to colon cancer (Speer et al., 2002) . Given the complexity of the AT phenotype, it is not surprising that a number of investigations have been undertaken to explore a possible functional link between ATM and calcium signaling. For instance, inhibitors of calmodulin and calmodulin-dependent protein kinase (CaMKII) are known to induce S-phase checkpoint delay in and confer cellular radiosensitivity on normal cells (Mirzayans et al., 1995; Enns et al., 1999) . The inability of radiationtreated AT fibroblasts to activate CaMKII (Famulski and Paterson, 1999) suggested that these cells are unable to mobilize intracellular Ca 2+ properly. This is indeed the case because AT cells show defective calcium ion mobilization in response to mitogenic factors (Famulski and Paterson, 1999) or after exposure to radiation (Yan et al., 2000) . Moreover, Purkinje cells isolated from ATM-disrupted mice display defects in the generation of Ca 2+ -dependent action potentials, caused by decreased calcium currents (Chiesa et al., 2000) .
Apart from growth factors, fibroblast proliferation depends heavily on [Ca 2+ ] o and its decrease impedes cell growth (Huang et al., 1995) . Changes in [Ca 2+ ] o are translated by CaR into the intracellular Ca 2+ transient which, in turn, is indispensable for the activation of proproliferative pathways (McNeil et al., 1998a) . Given that AT fibroblasts are retarded in their response to growth factors, we decided to explore the possibility that some of the proliferation abnormalities inherent in these cells may be linked to faulty sensing of [ ] o from a 'high' to a 'low' state greatly attenuated intracellular Ca 2+ release in normal (GM38) cells as judged by a sharp decline in fluo-3 fluorescence (Figure 1a) . Surprisingly, the opposite was observed when the AT (AT2BI) cells were assayed under the same conditions. As can be seen in Figure 1b , stimulating these cells in 'low' as opposed to 'high' [Ca 2+ ] o resulted in rapid and elevated mobilization of Ca 2+ . Data in Figure 1b and ] o . The generality of these findings was established by observing similar differences between normal (GM43) and AT (AT3BI, AT4BI or AT5BI) fibroblast strains. Moreover, a similar association between [Ca 2+ ] o and intracellular Ca 2+ release was found when the basic fibroblast growth factor was used as the stimulus (not shown). The increase in CaMKII autonomous activity is a direct consequence of the rise in intracellular Ca 2+ concentration, induced by radiation or serum-residing growth factors (Famulski and Paterson, 1999) . Hence, this same activity was monitored under the conditions described above. As might be predicted, the results for AT cells were completely opposite to those for normal cells ( Figure 1d) . In AT fibroblasts, however, once again the reverse was true, as quenching ambient Ca 2+ actually led to greatly enhanced levels of both phosphokinases. A similar pattern was seen for two additional AT strains (AT4BI and AT5BI). Quantitative analysis of the blots is presented in Figure 2 (lower panel), where a comparison has been made between the averaged data for two normal and three AT strains. These data vividly demonstrate that reducing ambient Ca 2+ levels from 'high' to 'low' had a pronounced stimulatory effect on serum-triggered phosphorylation of ERKs 1 and 2 in AT strains, whereas this process was greatly suppressed in normal strains. Figure 3 illustrates the dramatic differences in the kinetics of phospho-ERKs formation when AT cells were serum-stimulated in the presence of 'high' versus 'low' [Ca 2+ ] o . Clearly, the generation of phospho-ERKs was more rapid and efficient at low [Ca 2+ ] o . Similar data were obtained for another AT strain (AT5BI) (unpublished).
As noted earlier, changes in [Ca 2+ ] o alone lead to rapid activation of the MAPK pathway, and the CaR is directly implicated in this process (McNeil et al., 1998a) . The failure of serum-treated AT fibroblasts to phosphorylate ERKs 1 and 2 adequately in the presence of 'high' [Ca 2+ ] o suggests once again that these cells may be compromised in their ability to sense [Ca 2+ ] o properly. To test this notion, serum-starved normal and AT cell lines were stimulated with different concentrations of ambient Ca 2+ and the phospho-ERKs were monitored as described above. Normal cells, predictably, responded very poorly to 0.0022 and 0.125 mm Ca 2+ but favorably to 0.420 mm Ca 2+ (Figure 4, upper panel) . In sharp contradistinction, AT cells exhibited appreciable stimulation of ERKs phosphorylation at the lowest concentration of [Ca 2+ ] o (0.0022 mm). We therefore conclude that AT cells indeed sense extracellular Ca 2+ differently than their normal counterparts. Finally, we elected to determine whether the expression of CaR may be altered in AT cells. RNA from normal and AT fibroblast cultures was extracted and subjected to Northern analysis. As shown in Figure 4 (lower panel), the two cell lines exhibited no apparent difference in the amount of CaR message. Similar observations were made when another AT cell line (GM09607) was tested for either the [Ca 2+ ] o dependency or CaR message level. These findings imply that the defective [Ca 2+ ] o sensing by AT cells is via a post-transcriptional mechanism.
We reported previously that the ATM protein kinase is required for proper intracellular Ca 2+ mobilization and CaMKII activation in response to mitogenic (i.e. serum) stimulation (Famulski and Paterson, 1999) , thus disclosing a functional coupling between ATM, calcium signaling and cell proliferation. Results from the present study confirm and extend these earlier observations. In short, the current findings are consistent with a working model in which cell cycle progression of human fibroblasts is critically dependent upon their ability to sense ambient calcium concentration accurately and AT cells are severely impaired in this process. Our observations also strongly suggest that extracellular calcium is required for the proper activation of cells by growth factors, supporting the notion of crosstalk between various pro-proliferative and calcium signaling pathways (McNeil et al., 1998a) . ATM is implicated in growth factor-dependent mitogenesis, genome maintenance surveillance, membrane ruffling, vesicular trafficking and glucose uptake (Taylor, 1998 ; Nagasawa and . All ambient Ca 2+ concentrations were calculated using the Chelator software. A total of 10 GM38 and 10 AT2BE cells were analysed individually and the fluorescence values were then averaged. Arrow indicates time of serum addition. Curves were statistically different as determined by the two-tailed p-test (Po0.05) using the Prism software (GraphPad). Three independent experiments yielded similar results. Ca 2+ mobilization observed in both normal and AT cells could be prevented by thapsigargin, indicating its intracellular origin. (d): Serum-induced CaMKII autonomous activity was measured as described earlier (Famulski and Paterson, 1999) . Cells were stimulated for 20 s. Averaged values of two independent experiments are shown (Po0.05) Little, 1999; Rotman and Shiloh, 1999; Yang and Kastan, 2000) . Likewise, as mentioned earlier, ionized calcium is a well-known messenger involved in regulating a plethora of biological processes, including cell proliferation, differentiation and death (Berridge et al., 2000) . Thus, we postulate that loss of ATM function affects disparate homeostatic pathways that utilize both extra-and intracellular Ca 2+ , a signaling messenger widely acknowledged for its versatility. It remains to be established, however, as to whether ATM is directly or indirectly coupled to the Ca 2+ signaling machinery. On the one hand, given the strategic location and multiple phosphorylation targets of ATM, it is tempting to speculate a regulatory role of ATM over CaR and, in turn, signaling cascades. On the other hand, AT cells are known to be inherently subject to mild oxidative stress (Kamsler et al, 2001) . Ca 2+ -dependent and oxidative stress-induced signaling pathways are tightly interwoven, especially in the brain (Squier, 2001 ). In short, concentrations, immediately stimulated for 1 min, washed with ice-cold PBS, and lysed in 1 mm vanadate-containing buffer (Famulski and Paterson, 1999) . Phospho-ERKs 1* and 2*, present in 50 mg of total protein, were detected by Western blotting using phospho-p44/42 MAP Kinase E10 monoclonal antibody (Cell Signaling Technology), according to the manufacturer's recommendations. Blot images were analysed by the Foto/Analyst PC Image software. Equal loading was confirmed by staining blots with Ponceau Red (not shown). Lower panel: Quantitative analysis of Western blots: comparison between the averaged data for normal (GM38 and GM43, two independent experiments each) and three AT strains: AT2BE (two experiments), AT4BI (one experiment) and AT5BI (two experiments) fibroblasts, Po0.05 Figure 3 Time course of serum-dependent ERKs 1 and 2 phosphorylation in AT SV40-transformed (GM05849) fibroblasts. The (ERK1,2/actin) ratios given below the blots were derived by quantitative analysis of the images normalized to the time 0 value for the 'high' [Ca 2+ ] o conditions. Blots were stripped and reprobed for b-actin content using the monoclonal antibody AC-15 (SigmaAldrich) . Rows 1 and 2 correspond to SV40-transformed cell lines GM00637 (normal) and GM05849 (AT), respectively. Serum-starved cells were stimulated for 1 min in RPMI medium containing varying [Ca 2+ ] o . Equal loading was confirmed by staining blots with Ponceau Red (not shown). Lower panel: Expression of CaR message as revealed by Northern blot analysis. Lanes 1 and 2 correspond to cell lines GM00637 and GM05849, respectively. Total RNA was isolated using Tri-reagent (Sigma-Aldrich). RNA (10 mg) were run on a 1.2% agarose/1.1% formaldehyde gel and transferred to Hybond N+ membrane (Amersham Biosciences). The CaR probe, which spans a very highly conserved region of the CaR message sequence (McNeil et al., 1998b) , was synthesized from fibroblast RNA by RT-PCR. The porfobilinogen deaminase (PBGD) probe served as an internal control it will be important to determine whether the anomalies in Ca 2+ signaling manifested by AT cells signify direct participation of ATM in these cascades or arise secondarily as a consequence of chronic oxidative stress exacted by ATM deficiency.
Deregulated Ca 2+ signaling in AT cells may have serious consequences. Indeed, our preliminary observations (Pienkowska et al., 2002) have revealed that normal cells respond to low [Ca 2+ ] o by downregulating many genes, whereas the opposite is true for AT cells. Future experimentation along these lines may shed new light on the molecular basis of some of the most perplexing clinical hallmarks of AT (e.g. neurodegeneration, aberrant organogenesis and premature aging).
